In addition to symptom management, IV therapy can enhance overall wellbeing
Several GLP-1RAs, including exenatide, dulaglutide, semaglutide, and liraglutide, are approved for T2D, alongside tirzepatide, which also acts on glucose-dependent insulinotropic polypeptide (GIP) receptors
Compounded Oral Tirzepatide: Dual-Action GLP-1/GIP Receptor Activation The second formulation MEDVi introduced is compounded tirzepatide tablets, offering a more advanced metabolic approach through dual-pathway receptor activation
You may be a candidate if you: Meet medical eligibility for obesity/overweight or type 2 diabetes Are ready to pair medication with nutrition, movement, and sleep changes Want ongoing guidance and accountability from our clinical team We do not prescribe if there are contraindications or if it isnt clinically appropriate
Use the I'm Fabulous Vitamin C Serum on your face in the morning